1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 22
2.2 Major Growth Drivers 24
2.3 Market Restraints and Challenges 31
2.4 Emerging Opportunities and Market Trends 34
2.5 Porters Fiver Forces Analysis 38
3 Segmentation of Europe Market by Product 43
3.1 Market Overview by Product 43
3.2 Hemodialysis Device 45
3.3 Blood Filtration Device 46
3.4 CRRT Device 47
3.5 Hemoperfusion Device 48
3.6 Plasma Exchange Device 49
3.7 Other Products 50
4 Segmentation of Europe Market by Portability 51
4.1 Market Overview by Portability 51
4.2 Portable Equipment 53
4.3 Stationary Equipment 54
5 Segmentation of Europe Market by Indication 55
5.1 Market Overview by Indication 55
5.2 Renal Diseases 57
5.3 Sepsis 58
5.4 Other Indications 59
6 Segmentation of Europe Market by End User 60
6.1 Market Overview by End User 60
6.2 Hospitals and Clinics 62
6.3 Dialysis Centers 63
6.4 Other End Users 64
7 European Market 2021-2031 by Country 65
7.1 Overview of European Market 65
7.2 Germany 68
7.3 U.K. 71
7.4 France 73
7.5 Spain 75
7.6 Italy 77
7.7 Russia 79
7.8 Rest of European Market 81
8 Competitive Landscape 83
8.1 Overview of Key Vendors 83
8.2 New Product Launch, Partnership, Investment, and M&A 86
8.3 Company Profiles 87
Aethlon Medical, Inc. 87
Asahi Kasei Corporation 89
B. Braun Melsungen AG 90
Baxter International Inc. 91
Cerus Corporation 92
CytoSorbents Corporation 93
Fresenius SE and Co. KGaA 94
Healthwell Medical Tech. Co., Ltd. 95
Infomed SA 96
Jafron Biomedical Co., Ltd. 97
Kaneka Corporation 98
Nikkiso Co., Ltd. 99
Spectral Medical Inc. 100
SWS Medical Group 101
RELATED REPORTS 102